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Investigating pyridazine and phthalazine exchange in 
a series of iridium complexes in order to define their 
role in the catalytic transfer of magnetisation from 
parahydrogen 
Kate M. Appleby, Ryan E. Mewis, Alexandra M. Olaru, Gary G. R. Green, Ian J. 
S. Fairlamb and Simon B. Duckett*  
The reaction of [Ir(IMes)(COD)Cl], [IMes = 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, 
COD = 1,5-cyclooctadiene] with pyridazine (pdz) and phthalazine (phth) results in the 
formation of [Ir(COD)(IMes)(pdz)]Cl and [Ir(COD)(IMes)(phth)]Cl. These two complexes are 
shown by nuclear magnetic resonance (NMR) studies to undergo a haptotropic shift which 
interchanges pairs of protons within the bound ligands. When these complexes are exposed to 
hydrogen, they react to form [Ir(H)2(COD)(IMes)(pdz)]Cl and [Ir(H)2(COD)(IMes)(phth)]Cl, 
respectively, which ultimately convert to [Ir(H)2(IMes)(pdz)3]Cl and [Ir(H)2(IMes)(phth)3]Cl, 
as the COD is hydrogenated to form cyclooctane. These two dihydride complexes are shown, 
by NMR, to undergo both full N-heterocycle dissociation and a haptotropic shift, the rates of 
which are affected by both steric interactions and free ligand pKa values. The use of these 
complexes as catalysts in the transfer of polarisation from parahydrogen to pyridazine and 
phthalazine via signal amplification by reversible exchange (SABRE) is explored. The possible 
future use of drugs which contain pyridazine and phthalazine motifs as in vivo or clinical 
magnetic resonance imaging probes is demonstrated; a range of NMR and phantom-based MRI 
measurements are reported. 
 
 
 
 
1. INTRODUCTION 
Pyridazine and phthalazine are nitrogen-containing 
heterocycles with derivatives that have proven to be 
biologically active as anti-asthmatic,1 antifungal,2 anti-HIV-1,3 
anti-cancer4, 5 and anti-inflammatory drugs6-8 in addition to 
acting as treatments for Alzheimer’s disease.9,10 A wide range 
of pyridazine and phthalazine coordination complexes are 
known where ligation takes place through one or both of the 
nitrogen centres.11-17 When these ligands bind through a single 
nitrogen centre, the resulting complexes undergo both 
dissociative ligand loss and 1,2-metallotropic shifts through 
which the contiguous nitrogen donor atoms interchange 
positions.12 Such shifts were first described in 1972 for a series 
of ruthenium porphine complexes that contained an axially-
bound methylated pyridazine ligand.12 Rates for ligand shift 
and dissociation were obtained by nuclear magnetic resonance 
spectroscopy via line-shape analysis and subsequently the 
activation parameters for these processes were determined. The 
authors suggested that the sizeable, and positive, activation 
entropies that were observed are consistent with a dissociative 
pathway, although the precise mechanism for the 1,2-
metallotropic shift was not discussed.12  
More recent studies have focused on related octahedral systems 
where full ligand dissociation was more difficult and the 1,2-
metallotropic shift proceeded readily. Examples of such 
complexes can be found for ruthenium,13 chromium,14 tungsten, 
platinum11, 15, 16 and rhenium17 metals. In the more recent 
reports, the 1,2-metallotropic shift has been referred to as a 
‘haptotropic shift’ because of the potential to involve a -
bonding interaction between the two nitrogen centres during 
exchange. A theoretical study on an octahedral chromium 
carbonyl complex suggests that this shift can proceed within the 
solvent cage that surrounds a 16-electron intermediate.18 These 
processes are illustrated in Scheme 1. The tendency for ligand 
dissociation has been predicted to increase as the metal 
becomes less electron rich or the ligand trans to the exchanging 
site becomes more basic.19   
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Scheme 1 Proposed ligand exchange pathways of pyridazine, the blue nitrogen 
label is a visualization aid 
 
Ligand exchange processes are readily probed by Nuclear 
Magnetic Resonance (NMR) spectroscopy20, despite its low 
sensitivity.21 When slow, such exchange pathways are often 
followed by 1-D and 2-D nuclear Overhauser effect 
spectroscopy (NOESY).20 When fast, line-shape analysis allows 
exchange to be probed.22, 23 It has been shown that 
magnetisation transfer from parahydrogen (p-H2) can help to 
overcome the sensitivity problem associated with NMR.24, 25 
This is because, whilst p-H2 itself has no net spin angular 
momentum and is NMR silent, when used as a reagent in a 
reaction, products can be formed that possess non-Boltzmann 
nuclear spin distributions.26-29 The resulting signals that are 
detected in such NMR experiments can be many thousands of 
times stronger than normal. Parahydrogen induced polarisation 
(PHIP)30 that is created in this way has been shown to enable 
the study of reaction intermediates that cannot otherwise be 
detected by NMR spectroscopy because they exist in low 
concentration.31 In this traditional approach, the reactants must 
accept H2 and thus be both unsaturated and highly reactive.
31 
P-H2 has also been used in a non-hydrogenative manner,
32 
where molecules are hyperpolarised through the establishment 
of J-coupling with p-H2, whilst they are simultaneously bound 
to a metal centre in low field. This has also been achieved by 
radio frequency excitation.33-35 The non-hydrogenative process 
requires the substrate and p-H2 to exchange freely with their 
ligated forms in order to build-up a concentration of 
hyperpolarised substrate in solution. This effect has been 
termed signal amplification by reversible exchange (SABRE).36 
Polarisation transfer now proceeds over the short time period 
that the sample is stored in a small pre-determined magnetic 
field.25 This process has attracted interest because, unlike the 
traditional PHIP approach, it does not result in any chemical 
change to the detected species and reflects a novel catalytic 
process.37-40 A growing range of materials, including pyridine, 
nicotinamide, isoniazid, pyrazinamide and acetonitrile have 
been polarised in this manner.41-43  
Here, we examine the substrates pyridazine (pdz) and 
phthalazine (phth) using the SABRE approach, whilst taking 
the opportunity to simultaneously explore their coordination 
chemistry. [Ir(IMes)(COD)Cl] (1) (where IMes = 1,3-
bis(mesityl)imidazol-2-ylidene and COD = 1,5-cyclooctadiene) 
is used as the synthetic precursor in this study.44 We show that 
upon reaction of 1 with pyridazine or phthalazine,  
[Ir(COD)(IMes)(pdz)]Cl (2a) and [Ir(COD)(IMes)(phth)]Cl 
(2b) form, respectively. We find that these complexes add H2 
reversibly to yield highly reactive [Ir(H)2(COD)(IMes)(pdz)]Cl 
(3a) and [Ir(H)2(COD)(IMes)(phth)]Cl (3b). They subsequently 
undergo COD hydrogenation to form [Ir(H)2(IMes)(pdz)3]Cl 
(4a) and [Ir(H)2(IMes)(phth)3]Cl (4b). The mechanism of the 
ligand dissociation process exhibited by these complexes is 
probed by NMR spectroscopy and the roles of 4a and 4b as 
polarisation transfer catalysts in the SABRE of pyridazine and 
phthalazine are explored. Both NMR and phantom-based MRI 
measurements are reported to illustrate the wider benefits of 
hyperpolarisation. 
2. EXPERIMENTAL PROCEDURES 
All the experimental procedures associated with this work were 
carried out under nitrogen using standard Schlenk techniques or 
in an MBraun Unilab glovebox. The solvents used in the 
synthetic chemistry were dried using an Innovative Technology 
anhydrous solvent system, or distilled from an appropriate 
drying agent under nitrogen. Deuterated -methanol-d4, 
pyridazine and phthalazine were obtained from Sigma-Aldrich 
and used as supplied. [Ir(IMes)(COD)Cl] (1) was prepared 
according to literature methods.45 
2.1 Instrumentation and procedures All NMR measurements 
were recorded on Bruker Avance III series 400 MHz or 500 
MHz systems. NMR samples were prepared in 5 mm NMR 
tubes fitted with Young’s valves. Samples were degassed prior 
to p-H2 (3 bars) addition. Typical procedures for reactions with 
pyridazine and phthalazine are described. NMR 
characterisation data was collected using a range of 1 and 2 D 
methods that include nOe, COSY and HMQC procedures.46-50  
The slow dynamic processes exhibited by the complexes 
studied here were monitored by EXSY methods.51  
 [Ir(H)2(IMes)(pdz)3]Cl (4a). In a typical experiment, 1 (2 mg, 
3.12 µmol) and five equivalents of pyridazine (1.13 µL, 15.6 
µmol) were dissolved in methanol-d4 (0.5 mL) in a 5 mm NMR 
tube and the solution was degassed. H2, at a pressure of 3 bars, 
was added to the sample prior to it being heated to 348 K for 15 
minutes to fully activate it thereby forming 4a in solution.  
[Ir(H)2(IMes)(phth)3]Cl (4b). 1 (2 mg, 3.12 µmol) and five 
equivalents of phthalazine (2.03 mg, 15.6 µmol) were dissolved 
in methanol-d4 (0.5 mL) in a 5 mm NMR tube and the solution 
was degassed. H2 (3 bars) was added, and the sample was 
heated to 348 K for 15 minutes to form 4b.  
2.2 SABRE analysis NMR samples were prepared as above. 
Arrays of NMR measurements were collected using a range of 
substrate concentrations, as revealed in the supplementary. 1H 
NMR spectra were recorded with either /4 or π/2 excitation 
pulses in order to differentiate PHIP and SABRE effects. Each 
single-scan NMR spectrum was collected immediately after 
shaking the sample in a magnetic field of 65 G (unless 
otherwise specified), whilst under 3 bars of p-H2. Enhancement 
Journal Name ARTICLE 
This journal is © The Royal Society of Chemistry 2012 J. Name., 2012, 00, 1-3 | 3  
factors were calculated by comparing the peak areas in the 
resulting NMR spectra with those of analogous traces collected 
under normal H2 and Boltzmann equilibrium conditions. In 
order to do this, the peak areas of individual resonances in the 
corresponding normal NMR spectra were calibrated to 1 and 
enhancements calculated by comparing these values to those in 
the polarised spectra. Total signal enhancements were 
calculated by multiplying this enhancement value by the 
number of protons in the group and summing across the 
molecule. 
2.3 Polarisation transfer field measurements were made 
using a dedicated hyperpolarisation apparatus.44 Samples were 
first prepared in 3 ml of methanol-d4 in an ampoule containing 
10 mg of 1 and 5 equivalents of pyridazine or phthalazine. The 
solution was degassed, and the ampoule was filled with 3 bars 
pressure of H2 and heated to 348 K overnight to form 4a or 4b. 
At this point, the resulting solutions were introduced into the 
flow system and the SABRE effect monitored for PTFs that 
ranged from 0.5 to 140.5 G, in steps of 10 G. This involved the 
collection of a series of single-scan spectra using either π/2 
pulses or shaped pulses50, 52 for the multiple quantum filtered 
experiments. The peak integrals in the resulting NMR spectra 
were compared to those of a thermally polarised spectrum to 
determine signal enhancement factors.   
2.4 EXSY measurements A series of exchange spectroscopy 
(EXSY) measurements were made to probe the dynamic 
behaviour of these systems.53 This process involved the 
selective excitation of a single resonance and the subsequent 
measurement of a 1H NMR spectrum at time, t, after the initial 
pulse. The resulting measurements consisted of a series of data 
arrays such that t was varied over 10 values, typically from 0.1 
to 1.0 s. The precise values were varied with temperature to suit 
the speed of the process. Data was collected for a range of 
temperatures and sample concentrations as tabulated in the 
supplementary.  
2.5 Kinetic analysis Integrals for the interchanging peaks in the 
associated 1H EXSY spectra were obtained and converted into a 
percentage of the total detected signal. These data were then 
analysed as a function of the mixing time according to a 
differential kinetic model.54 Rates of exchange were determined 
by employing the solver add-on in Microsoft EXCEL to 
minimize the sum of the residuals in the associated least mean 
squares analysis. The rate constants obtained in this way were 
doubled when calculating barrier heights to account for step 
reversibility.55 Errors associated with the calculated rate 
constant were determined by the Jackknife procedure of 
Harris.56  
2.6 Image Acquisition and Processing For the imaging 
experiments, samples containing 4a and 4b were prepared as 
described earlier. All data was then acquired on a 400 MHz 
Bruker spectrometer equipped with a micro imaging gradient 
system (1 T/m) and a standard 30 mm 1H-13C double resonance 
birdcage. For the SABRE experiments the sample tubes were 
filled with 3 bars of p-H2 and shaken in the stray field of the 
MRI magnet (ca. 70 G). As a reference, images of the samples 
with Boltzmann-equilibrated magnetisations were recorded in 
conjunction with a recycle delay of 100 s and 512 averages.  
A standard rapid acquisition with refocused echoes (RARE)57 
sequence composed of a train of 64 π pulses separated by an 
echo time (TE) of 8.15 ms (effective echo time, TEeff = 260 
ms) was used to collect the images. According to Hennig et al., 
by using a relatively small number of echoes, combined with a 
short echo time, the effect of transverse relaxation is minimised 
and the image contrast is dictated by spin density.57 All images 
used a field of view (FOV) of 30 x 30 mm, a slice thickness of 
5 mm and a 64 x 64 matrix size. This led to a raw resolution of 
0.47 x 0.47 x 5 mm3.  Data were processed by FT and zero 
filled to 128 x 128 (resulting digital resolution: 0.23 x 0.23 x 5 
mm3) using a sine bell noise filter. Signal-to-noise (SNR) 
values were calculated using an algorithm that assumed a Rice-
type noise distribution. 
3. EXPERIMENTAL RESULTS  
3.1. Reaction of [Ir(IMes)(COD)Cl] (1) with pyridine. It has 
already been reported that when 1 reacts with pyridine in 
methanol-d4 it forms [Ir(COD)(IMes)(py)]Cl.
44 When pyridine 
is replaced with either pyridazine or phthalazine the 
corresponding solutions immediately change colour from 
yellow to orange due to the formation of the analogous 
complexes [Ir(COD)(IMes)(pdz)]Cl (2a)  and 
[Ir(COD)(IMes)(phth)]Cl (2b). Both of these complexes have 
been characterized by NMR spectroscopy and mass 
spectrometry. Attempts to follow this process by stop-flow UV-
Vis spectroscopy, with a dead-time of 0.6 ms, failed because 
the reaction was too rapid.  
3.2. Ligand exchange exhibited by [Ir(COD)(IMes)(pdz)]Cl 
(2a)  and [Ir(COD)(IMes)(phth)]Cl (2b). When these 
products were analysed by 1H NMR spectroscopy, signals for 
the bound N-heterocycles could not be resolved at room 
temperature. To overcome this, a series of NMR spectra were 
collected at 253 K. The supplementary information presents the 
corresponding 1H, 13C and 15N resonance assignments for these 
species.  A series of 2-D nOe spectra were also collected at 253 
K. These confirmed that the NCHCH and NCH protons of the 
pyridazine ligand in 2a and the phthalazine ligand in 2b switch 
their nitrogen binding sites on a timescale of 0.5 seconds (see 
Scheme 2). The broadening of the NMR signals for these 
ligands, seen at room temperature, is due to this rapid 
exchange. NMR signals for the free ligand were also present in 
these spectra, although no exchange into them was observed at 
this temperature, or upon warming to 298 K. This is therefore 
an intramolecular process.  
The intramolecular nature of this process means that the 1,2-
metallotropic shift is haptotropic. It occurs via an intermediate 
with an η2-N=N coordination mode according to Eaton et al12, 
rather than dissociation which would lead to 14-electron 
[Ir(COD)(IMes)]+ and the observation of exchange with the 
free ligand pool.  
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Scheme 2 Ligand exchange pathway exhibited by 2a
 
The rate of the haptotropic shift was determined over the 
temperature range 240 to 260 K by EXSY spectroscopy. 
Exchange in 2a, between the proton signal at δ 7.69 
(corresponding to IrNCHCH) and that at δ 7.51 (corresponding 
to IrNNCHCH), was probed.  The analogous process in 2b was 
followed between 235 and 255 K by selecting the proton signal 
at δ 9.55 (corresponding to IrNCH) and observing its exchange 
into the signal at δ 8.37 (corresponding to IrNNCH). The 
associated exchange rates were quantified by data fitting (see 
SI). Figure 1 shows a typical exchange profile, while Table 1 
lists the corresponding rate data. The activation parameters for 
these processes were calculated by Eyring analysis and are 
given in Table 2. They are similar to those reported.11, 14-17 
 
Figure 1. Signal intensity profile change associated with the interchange of the 
IrNCHCH (green squares) and IrNNCHCH (blue circles) resonances of 2a, 
according to Scheme 2 above, as a function of reaction time (t). Simulated data is 
presented as the solid line.  
Table 1. Ligand exchange rate constants of 2a and 2b in methanol-d4 solution 
Temperature / K Rate of haptotropic shift / s-1 
2a 2b 
235 - 0.923 ± 0.001 
240 0.729 ± 0.001 1.873 ± 0.003 
245 1.501 ± 0.003 3.955 ± 0.003 
250 3.155 ± 0.002 7.318 ± 0.004 
255 5.80 ± 0.01 13.426 ± 0.004 
260 12.74 ± 0.02 - 
 
Table 2. Activation parameters for the haptotropic shift exhibited by 2a and 
2b in methanol-d4 solution 
Complex ΔH‡ / kJ mol-1 ΔS‡ / J mol-1 K-1 ΔG‡ / kJ mol-1 
(300 K) 
2a 71.3 ± 0.3 57 ± 1 54.2 ± 0.4 
2b 66.0 ± 0.1 43.0 ± 0.6 53.1 ± 0.2 
 
The enthalpy of activation for the haptotropic shift of 2a is 
larger than that of 2b by 5 kJ mol-1. This difference suggests 
that the Ir-pdz bond is stronger than the Ir-phth bond and yet 
the reported pKa values of pyridazine and phthalazine are 2.33 
and 3.50, respectively.58 We suggest that steric interactions 
result in the smaller activation entropy gain for binding site 
interchange of the larger and more basic ligand phthalazine 
ligand. 
3.3. Addition of H2 to [Ir(COD)(IMes)(pdz)]Cl (2a)  and 
[Ir(COD)(IMes)(phth)]Cl (2b). Two separate methanol-d4 
solutions of 2a and 2b were exposed to a 3 bar pressure of 
hydrogen at 240 K. In both cases the solutions changed colour 
from orange to colourless due to the formation of 
[Ir(H)2(COD)(IMes)(pdz)]Cl (3a) and 
[Ir(H)2(COD)(IMes)(phth)]Cl (3b), respectively. These 
complexes are easily identified by 1H NMR spectroscopy as 
they yield two coupled hydride resonances, which in the case of 
3a lie at δ –13.84 and –17.69, and for 3b lie at δ –13.87 and –
17.55.  As the hydride ligands of both these products are 
chemically inequivalent, they must adopt one of two possible 
product geometries, assuming that hydrogen addition follows 
the expected concerted route, as shown in Scheme 3.59 In one of 
these product geometries, the hydride ligands lie trans to the N-
heterocycle and COD (3a) while in the second they lie trans to 
IMes and COD (3a’).60  
Scheme 3 Products of H2 addition to 2a 
 
One route to differentiate these two orientations is to recognise 
that a trans H-Ir-15N coupling is significantly larger than a cis 
coupling. When a 15N-optimized HMQC NMR spectrum was 
recorded to probe this, strong cross-peaks were found between 
the hydride signals at δ –17.55 (of 3b) and –17.69 (of 3a) and 
the nitrogen signals of the bound N-heterocycle at δ 294.17 and 
266.53 respectively. This confirms their mutual trans 
orientation and that 3a and 3b form by H2 addition over the 
COD-Ir-N axis of 2a and 2b respectively. This is consistent 
with the nature of the ligands determining the direction of 
addition, which in this case favours addition over the axis 
containing the weak nitrogen donor rather than the strong IMes 
ligand.61 
Furthermore, the corresponding 2D-1H COSY NMR spectrum 
contains cross-peaks between the hydride ligand signals at δ –
13.84 (of 3a) and –13.87 (of 3b) and the inequivalent proton 
signals that arise from the two CH environments in the bound 
COD that are trans to hydride. In the case of 3a these COD 
signals appear at δ 5.09 and 4.45. Both species 3a and 3b have 
been fully characterised by NMR spectroscopy.  
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We note that when solutions of 3a and 3b are degassed, 
reductive elimination of H2 occurs and 2a and 2b reform. H2 
addition is therefore a reversible process. These complexes are 
examples of a relatively rare class of alkene dihydride species 
that are typically active in alkene hydrogenation. A related 
iridium pyridylpyrrolide COD complex has been shown by 
Searles et al to reversibly bind hydrogen in a similar way.62 
3.4. Reaction of [Ir(COD)(H)2(IMes)(pdz)]Cl (3a) and 
[Ir(COD)(H)2(IMes)(phth)]Cl (3b) with p-H2. One route to 
probe the concerted nature of this process is to employ p-H2. 
This is because PHIP requires the pair-wise transfer of H2. 
When the H2 atmosphere of these samples is replaced with p-
H2, and the NMR tube shaken immediately prior to 
1H NMR 
signal detection, dramatic hydride signal enhancements result. 
These signal enhancements are illustrated in Figure 2 for 3a. 
The experimentally observed signal enhancement was 90-fold 
for the sharper signal at δ –13.84 due to Ha and 66-fold for the 
broader signal at δ –17.69 due to Hb. For 3b, smaller 52-fold 
and 35-fold signal enhancements are observed for the 
corresponding resonances. 
 
Figure 2. Selected regions of a p-H2-enhanced 
1H NMR spectrum of 3a, showing 
free (stars) and bound pyridazine (left) and 2-CH COD (middle) signal 
enhancements resulting from low-field polarisation transfer in addition to the 
corresponding PHIP enhanced hydride signals for Ha and Hb (right). The vertical 
expansion scales, relative to the original spectrum, are indicated.   
In order to compare the reactivity of these complexes we 
prepared a sample that contained approximately equal amounts 
of pyridazine and phthalazine (6.73 equivalents of phth and 
6.16 equivalents of pdz relative to 1 as measured by NMR). 
Upon NMR examination, the binding of phthalazine proved to 
dominate over that of pyridazine, with the ratio of 2b : 2a being 
3.7 : 1. When corrected for these slightly unequal starting 
ligand concentrations, the equilibrium ratio is 3.40 : 1 and 
ΔΔG02a-2b at 240 K is approximately –2.44 kJ mol
-1 with 2b 
being more stable than 2a. 
The normalized PHIP enhancements that are exhibited by the 
hydride signals of species 3a and 3b upon p-H2 addition at 240 
K are 56.8–fold and 38.2–fold, respectively. As the p-H2 
concentration in solution is constant and its purity identical at 
the point of measurement, these numbers can be compared. If 
we assume that both complexes retain the same level of p-H2 
derived magnetisation at the point of their formation then their 
relative signal intensities will be proportional to the product of 
their rates of reaction and concentration. The greater abundance 
of 2b (x 3.7), in combination with the hydride signal 
enhancement levels, suggests that the rate of H2 addition to the 
more stable 2b is a factor of ca. 4.7 slower than that to 2a.  
The PHIP effect that is seen in these hydride signals vanishes 
rapidly upon the introduction of the sample into the NMR probe 
at 240 K. This is because the hydrides do not undergo H2 
elimination on the NMR timescale at this temperature. 
However, if the sample is removed from the magnet and shaken 
to dissolve fresh p-H2, the PHIP effect is re-established in the 
associated hydride ligand signals. This is due to the transiently 
higher temperatures that the sample experiences whilst shaken. 
Under these conditions, however, 3a and 3b are present and it 
is their exchange rates that control the level of PHIP. In 
subsequent NMR spectra the levels of observed signal 
enhancement are almost equal, at 27.6-fold and 20.1-fold. 
However, in the corresponding thermally equilibrated NMR 
spectra, at 240 K, the phthalazine dihydride complex 3b still 
dominates, now by a factor of 3.2. In fact, these data suggest 
that ΔG03a-3b is –2.33 kJ mol
-1 at 240 K. Based on these data we 
can conclude that less stable 3a undergoes more rapid H2 loss 
than 3b. 
Limited evidence for the formation of the isomers 3a’ and 3b’ 
of Scheme 3 was observed. This is in agreement with the IMes-
Ir-COD axis being the most electron rich and the most sterically 
hindered, and therefore the least able to promote H2 addition 
across it.59, 63 Hydride signals for these species were seen at  -
9.12 and -13.48 for 3a' and at  -9.11 and -13.48 for 3b', with 
very low intensity. The values of the hydride chemical shifts in 
this pair of complexes reflect their trans-orientations to soft 
carbene and COD ligands.64 The signals did not exhibit PHIP, 
despite being coupled.  They are also not visible in the low 
temperature 1H NMR spectra but can be observed at 298 K. 
Upon cooling from this temperature, in an effort to trap the 
species, the corresponding hydride signals vanish and only 
those for 3a and 3b remain.  
We conclude from these data that stability increases in the order 
2a<2b<3a<3b and that the addition of H2 proceeds more 
rapidly to 3a.  
3.5. Observation of the SABRE effect in the NMR signals of 
[Ir(COD)(H)2(IMes)(pdz)]Cl (3a) and 
[Ir(COD)(H)2(IMes)(phth)]Cl (3b). The SABRE effect is 
evident in the first scan of these PHIP enhanced 1H NMR 
spectra. This is reflected in the observation of enhanced 
pyridazine resonances for 3a at δ 9.06, 9.03, 7.91 and 7.62, as 
shown in Figure 2. Additional enhanced signals corresponding 
to free pyridazine at δ 9.27 and 7.85 (the NCH and NCHCH 
environments respectively) are also observed. The ratio of the 
NCH signal for the free and bound ligand is 4.29 : 1. These data 
confirm that 3a undergoes pyridazine loss on a shorter 
timescale than NMR relaxation.  
One surprising feature of these chemical systems is the 
polarisation of bound CH proton environments of the 4-COD 
ligand, at δ 5.09 and 4.45 in the case of 3a, although no free 
COD, COE or COA signals are evident. We note that there is 
no evidence in the corresponding EXSY spectra to suggest that 
the bound COD reversibly accepts a hydride ligand.65 SABRE 
-14 -15 -16 -17 ppm89 ppm 5 ppm
x2 x4
// //
x0.5
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magnetisation transfer proceeds readily from the hydride 
ligands of 3a and 3b into the ligands that are trans to them. 
3.6. Formation of the efficient magnetisation transfer 
catalysts [Ir(H)2(IMes)(pdz)3]Cl (4a) and 
[Ir(H2(IMes)(phth)3]Cl (4b). Both 3a and 3b were stable at 
temperatures up to 250 K, with their hyperpolarisation effects 
disappearing in solution after several seconds. Above this 
temperature, however, the COD ligand hydrogenates and forms 
COA; there is no NMR evidence for COE.65 The vacant sites 
that are created by the hydrogenation of COD then become 
occupied by two further pyridazine or phthalazine ligands. This 
leads to the formation of [Ir(H)2(IMes)(pdz)3]Cl (4a) and 
[Ir(H)2(IMes)(phth)3]Cl (4b) respectively. These reactions take 
approximately one hour to go to completion at 298 K. Both 4a 
and 4b have been characterised by NMR spectroscopy and 
mass spectrometry. The reaction pathway for the conversion of 
1 into 4a is illustrated in Scheme 4. A weak unassigned hydride 
signal is seen in these 1H NMR spectra at  -22.87. This may 
correspond to an intermediate with a similar structure to that of 
[IrH(1--C8H13)(PMe3)(NCCH3)2]BF4, which provides a 
diagnostic hydride resonance at δ –20.35.65 
Scheme 4 Products of H2 and pyridazine addition to 1 
 
The organic region of a 1H NMR spectrum of 4a is shown in 
Figure 3. The corresponding hydride region, which is not 
displayed, contains a single peak, at δ –21.47, due to the two 
chemically equivalent, but magnetically distinct, hydride 
ligands of this complex. The organic region of this NMR 
spectrum is complicated as the symmetry of pyridazine is 
broken upon binding to the metal centre. Seven new aromatic 
1H resonances are visible, four of which appear as simple 
doublets, at δ 9.62, 9.31, 8.75 and 8.29 with integral ratios of 1 
: 2 : 2 : 1 respectively, relative to the 2-proton hydride ligand 
signal. Their doublet nature means that they arise from 
pyridazine NCH environments, and their relative areas confirm 
the presence of a single axial ligand (δ 9.62 and 8.29) and two 
equivalent equatorial ligands (δ 9.31 and 8.75). The remaining 
three multiplets, at δ 7.62, 7.48 and 7.40, have integral ratios of 
2 : 1 : 3 respectively and arise from the remaining NCHCH 
environments. The arrangement of these groups around the 
metal centre was confirmed by nOe measurements at 300 K 
with mixing times of ≥ 0.6 s. These data revealed that both the 
equatorial IrNCH and IrNNCH environments interact with 
methyl-IMes protons that resonate at δ 2.22 and 2.04. These 
connections confirm that the equatorial pyridazine ligands lie in 
close proximity to the IMes ligand. Complex 4a was further 
characterised by extensive COSY, 13C-optimised HMQC and 
15N-optimised HMQC measurements.  
The phthalazine analogue of 4a, [Ir(H)2(IMes)(phth)3]Cl (4b)  
was characterised in a similar way. Part of its 1H NMR 
spectrum is shown in Figure 3b. A single hydride peak is also 
observed for this product, at δ -21.0. Peaks at δ 9.63, 8.26 and 
8.15 correspond to the NCH, NCHCCH and NCHCCHCH 
environments of free phthalazine respectively. Four singlets are 
observed at δ 10.28, 10.16, 9.27 and 8.60 with integral ratios of 
1 : 2 : 2 : 1. These resonances correspond to the bound NCH 
environments of 4b and can be broken down into axial and 
equatorial contributions. NMR data for 4a and 4b is given in 
the SI.    
 (a) 
 
(b) 
 
Figure 3. 1H NMR spectra of 4a (a) and 4b (b) showing the 
organic region with key equatorial and axial IrNCH and 
IrNNCH resonances. Free substrate resonances are also shown 
(stars).  
 
Table 3. 15N NMR chemical shift () and  data for complexes 4a and 4b 
(where  = free-bound) 
 4a ∆
δ 
4b ∆
δ 
15N equatorial Ir-N=N- 326.2 -57.0 299.7 -49.9 
15N equatorial Ir-N=N- 390.0 6.8 360.9 11.3 
15N axial Ir-N=N- 305.8 -77.4 278.8 -70.8 
15N axial Ir-N=N- 392.2 9.0 362.8 13.2 
 
3.7. Using 15N chemical shifts to support the 
characterisation of [Ir(H)2(IMes)(pdz)3]Cl (4a) and 
[Ir(H2(IMes)(phth)3]Cl (4b). Modern NMR methods, 
specifically inverse sequences, allow insensitive nuclei, such as 
15N, to be detected when they are present at natural 
7.47.67.88.08.28.48.68.89.09.29.49.6 ppm
----- -----
8.08.28.48.68.89.09.29.49.69.810.0 ppm
-----
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abundance.66 15N NMR data, collected by inverse HMQC 
methods for 4a and 4b are detailed in Table 3. In the case of 4a, 
pyridazine binding to iridium moves the 15N chemical shift of 
the free ligand from δ 383.2, to δ 326.2, when bound trans to 
hydride, and to δ 305.8 when bound trans to carbene. The value 
of the change in chemical shift on binding δ (free-bound) has 
been suggested to relate to the extent of interaction with the 
metal.67 As revealed in Table 3, the largest δvalue is 
observed for the axial N-heterocycle arrangement with the in-
plane change being 30 % smaller. This suggests that there is a 
weaker in-plane ligand interaction as a consequence of the 
greater trans-influence of hydride relative to IMes.67 The 
corresponding δvalues for the remote nitrogen centres in 
these ligands are much smaller and positive in sign thereby 
illustrating that electron density surrounding them is 
significantly less perturbed by the introduction of a metal-
ligand interaction. 
3.8. Hydride and N-heterocycle ligand exchange dynamics 
of [Ir(H)2(IMes)(pdz)3]Cl (4a) and [Ir(H)2(IMes)(phth)3]Cl 
(4b). The ligand exchange pathways of 4a and 4b have been 
explored by NMR spectroscopy. The samples examined here 
employ d4-methanol as the solvent. A series of 1D EXSY 
measurements were undertaken, at 10 different temperatures, 
and both ligand exchange and H2 loss pathways were revealed. 
These processes were too slow to be detected at temperatures 
below 280 K and the upper limit of our measurements was 325 
K, due to the boiling point of methanol. At this temperature, the 
exchange rates were too slow to observe any line-shape 
changes.  
In the first of our EXSY experiments, peaks corresponding to 
the NCH environment of the axial ligands in 4a and 4b were 
probed. No magnetisation transfer was observed from these 
sites, at 320 K, and we conclude that the axial ligands in both 
4a and 4b remain bound to the metal on this timescale and that 
their involvement in exchange can be neglected. This 
observation matches the higher strength of interaction predicted 
through the larger 15N-δ value detailed earlier. In contrast, 
when the equatorial ligands of 4a and 4b were probed, 
magnetisation transfer indicative of ligand exchange and the 
‘shifting’ of the equatorial ligand’s nitrogen binding centre was 
observed by a 1,2-metallotropic shift. A typical EXSY trace is 
shown in Figure 4. Both of these processes are common in such 
systems.11-17 Shifting coordination from one nitrogen centre to 
the other is likely to proceed via a trigonal bipyramidal 
transition state, rather than a Berry-pseudorotation, in 
accordance with the molecular orbital studies by Alvarez et 
al.19 When the hydride ligand signals of 4a and 4b were 
examined, in a similar way, exchange into the signal for H2 was 
observed. 
The rate constants for these processes were calculated by 
analysing an array of EXSY spectra that were recorded with a 
series of magnetisation transfer times. SI sScheme 2 illustrates 
pictorially the exchange processes that occur with pyridazine, 
and the extracted rate constants as a function of temperature are 
also available. Eyring analysis of these data provided the 
activation parameters that are shown in Table 4. The barrier to 
Ir-N bond rupture (dissociation) is twice the sum of the full 
ligand loss rate if upon reaching the transition state there is an 
equal probability of a null-reaction. The haptotropic shift was 
considered as a separate intramolecular pathway in this 
analysis. 
 
Figure 4. 1D EXSY 1H NMR spectrum, illustrating the extent of magnetisation 
transfer from the δ 8.75 equatorial IrNNCH resonance of 4a into the δ 9.23 free 
pyridazine signal and the δ 9.31 equatorial IrNCH resonance of 4a after a 
magnetisation transfer time of 1 second.  
 
Table 4. Activation parameters for the indicated ligand exchange processes in 
4a and 4b in methanol-d4 
Process ΔH‡ 
/kJ mol-1 
ΔS‡ 
/J K-1 mol-1 
ΔG‡(300 K) 
/kJ mol-1 
Complex 4a 4b 4a 4b 4a 4b 
Substrate 
dissociation 
97.9 
± 0.3 
92.0 ± 
0.3 
85 ± 
1 
62 ± 
1 
72.5 ± 
0.3 
73.3 ± 
0.3 
Haptotropic 
shift 
94.3 
± 0.4 
78.13 ± 
0.06 
72 ± 
1 
17.4 
± 0.2 
72.6 ± 
0.3 
72.93 ± 
0.06 
H2 loss 95.6 
± 0.2 
83.6 ± 
0.1 
82.4 
± 0.8 
39.8 
± 0.4 
70.9  
± 0.3 
71.6 ± 
0.2 
 
3.9. Mechanism of pyridazine and phthalazine ligand 
dissociation and binding site shift in [Ir(H)2(IMes)(pdz)3]Cl 
(4a) and [Ir(H)2(IMes)(phth)3]Cl (4b). Exchange behaviour 
was probed as a function of substrate concentration at 285 K 
(see supplementary sTables 6-10). A plot of ligand exchange 
rate versus ligand concentration, for a constant concentration of 
1, is presented in Figure 5b for 4a and Figure 5c for 4b. It can 
be seen from these data that the experimental rate constants for 
pyridazine and phthalazine ligand dissociation are unaffected 
by an increase in the free ligand concentration (Figures 5b and 
5c). This zero-order rate behaviour is consistent with a 
dissociative process and a haptotropic shift.18  
The ΔH‡ values in Table 4 reflect the associated Ir-N bond 
energies and the barriers to ligand exchange. For each pair of 
complexes, the enthalpy change on reaching the transition 
states for the haptotropic shift is lower than that of dissociation. 
Bulkier phthalazine has a weaker Ir-N bond and hence smaller 
ΔH‡ term. Consequently, the Ir-N bond is longer and the gain 
in entropic freedom on reaching the transition state for both 
phthalazine dissociation and shifting falls. The two effects act 
to compensate each other such that their ΔG≠(300 K) values are 
similar. This is particularly noticeable in the haptotropic shift, 
where the ΔH‡ and ΔS‡ terms of phthalazine are lower by 16.2 
kJ mol-1 and 55 J K-1 mol-1 respectively. 
 
(a) 
8.78.88.99.09.19.29.3 ppm
IrNCH   NCH                                  IrNNCH 
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(b) 
 
(c) 
 
(d) 
 
Figure 5. Plot showing how the rate of ligand exchange varies as a function of 
ligand concentration for 4a and 4b: (a) [H2] dependence, (b) [pyridazine] 
dependence (c) [phthalazine] dependence, (d) plot of the inverse of the H2 loss 
rate versus ligand concentration.  
As mentioned previously, the literature values for the pKa of 
pyridazine and phthalazine are 2.33 and 3.50 respectively. Our 
observed values of 15N-δupon ligand binding were –57.0 and 
–49.9 respectively. Less basic pyridazine exhibits a stronger 
bonding interaction than phthalazine; ground state steric effects 
must therefore control the Ir-N bond strength.  
3.10. Mechanism of H2 loss from [Ir(H)2(IMes)(pdz)3]Cl (4a) 
and [Ir(H)2(IMes)(phth)3]Cl (4b). The rate of H2 loss from 4a 
depends on the pressure of H2 for a constant substrate excess, as 
shown in Figure 5a. However, when the H2 loss pathway was 
monitored at constant H2 pressure as a function of substrate 
concentration, inhibition was observed (Figures 5b and 5c). The 
pseudo-rate constant for H2 loss is inversely proportional to the 
substrate concentration (Figure 5d). This behaviour matches 
with that predicted by DFT for the related pyridine system in 
which the dihydrogen-dihydride intermediate 
[Ir(H)2(H2)(IMes)(py)]Cl is involved in H2 exchange.
44 The 
inhibition by substrate occurs as it reacts with 16-electron 
[Ir(H)2(IMes)(sub)]Cl rather than H2.  
3.11. SABRE 1H NMR signal enhancement by 
[Ir(H)2(IMes)(pdz)3]Cl (4a) and [Ir(H)2(IMes)(phth)3]Cl 
(4b). Both 4a and 4b undergo ligand exchange on the NMR 
timescale. Such exchange is necessary for the SABRE effect to 
successfully hyperpolarise a material. We investigated the 
effect of shaking a sample of 1 (5.2 mM), containing 5 
equivalents of pyridazine and 3 bars of p-H2, in the Earth’s 
magnetic field for 10 seconds at 298 K, prior to collecting a 1H 
NMR spectrum. 1H NMR signal enhancements are observed in 
all of the free and bound equatorial substrate resonances, and 
the hydride resonance of these complexes. No evidence for the 
formation of any dinuclear complexes was evident, and the 
phase of the observed hyperpolarised signals for the 
corresponding free and bound sites were identical.   
Upon integration, the free pyridazine NCH resonance was 180-
times larger than the corresponding signal recorded when the 
magnetisation was probed under thermal equilibrium 
conditions. The total signal enhancement of the two resonances 
in this substrate was 410-fold. When a similar phthalazine 
sample was probed in an identical way, the hydride signal for 
4b, and all of the free and equatorially bound substrate 
resonances were again enhanced. In this case, the 
corresponding free NCH resonance was 85-fold enhanced and 
the total molecular enhancement was 195-fold. The net 
enhancement factor therefore drops significantly on moving 
from pyridazine to phthalazine, despite their comparable ligand 
loss rates. Furthermore, the remote ring of phthalazine, which is 
connected by a 5-bond coupling of 0.43 Hz into the first ring is 
only weakly polarised by comparison to the first ring (14%). 
The underlying difference of 2.1-fold between the polarisation 
levels observed for these two molecules cannot be accounted 
for by a spin dilution effect (the consequence of sharing the 
magnetisation of p-H2 with 6 rather than 4 receptor protons). 
By implication, the J-coupling that exists between the hydride 
and Ir-NCH protons of pyridazine must be larger than that to 
phthalazine, hence better polarisation transfer results; this fits 
with the predicted shorter bond length. 
The concentration dependence on the level of SABRE seen in a 
series of 1H NMR spectra recorded with /2 pulses is illustrated 
in Figure 6a for pyridazine and 6b for phthalazine. It is clear, in 
these data, that the proton resonance which corresponds to the 
site next to nitrogen is most strongly enhanced with 4a 
delivering a 380-fold NCH intensity gain when a 17 mM 
concentration of pyridazine is employed in conjunction with a 
metal concentration of 6.24 mM. The signal enhancement level 
falls as the substrate concentration increases, when a constant 
metal concentration is maintained. In addition to reflecting 
spin-dilution, this change also results in a progressive reduction 
in the rate of H2 exchange. Both of these effects reduce the 
levels of signal gain seen for all of the protons of pyridazine 
and phthalazine. Surprisingly, when the inverse of the sum of 
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the enhancement levels is plotted against equivalents of free 
substrate, a negative linear relationship can be seen (Figure 6c). 
 
(a) 
(b)  
(c)  
Figure 6. Plots showing the effect of substrate concentration, for a constant 
metal concentration, on the level of pyridazine and phthalazine 
hyperpolarisation achieved by 4a (a) and 4b (b) with plot (c) revealing how the 
reciprocal of the total enhancement level relates to substrate concentration.  
 
The signal intensity gains that were observed in these 1H NMR 
spectra also varied with temperature as shown in Figure 7. A 
continuous growth in the hyperpolarisation level with 
increasing temperature is observed between 273 K and 323 K, 
the highest temperature used. In the first of these samples, the 
concentration of free pyridazine was 12.3 mM while in the 
second, the concentration of free phthalazine was 14.1 mM. 
The corresponding rates of H2 loss at 323 K were estimated to 
be 29.7 s-1 and 13.49 s-1 respectively. This suggests that an 
optimal ligand exchange rate has not been reached at 323 K, 
despite the short lifetimes of these complexes. 
The gain in signal strength appears to be linear with 
temperature, although the gradient exhibited by the 5 resonance 
intensities differs substantially, falling with distance from the 
ligation site. This change mirrors the efficiency of their 
polarisation. The gradients shown for the pyridazine signals are 
larger than those for phthalazine in accordance with its greater 
exchange rate sensitivity to temperature. Furthermore, the 
sensitivity to temperature falls as the substrate excess increases 
(Figure 7c). This observation can be rationalised by the fall in 
H2 exchange rates with increase in ligand concentration. 
 
 
(a)   
(b)  
(c)  
Figure 7. Plots of reaction temperature versus (a) pyridazine (12.3 mM free pdz, 
2-fold excess) and (b) phthalazine (14.1 mM free phth, 2.3-fold excess) proton 
hyperpolarisation level under SABRE. Plot (c) presents analogous data when the 
pyridazine excess is 12.1-fold (75.1 mM free pdz). 
3.12. Probing the effect of sample dilution on the level of 
SABRE enhancement. In the case of pyridazine, the effect of 
the concentration of 4a (with the excess of free pyridazine kept 
constant) on the level of SABRE enhancement has been 
rigorously studied. The smallest ligand excess delivered the 
largest level of polarisation, alongside a metal concentration of 
2.8 mM. The maximum total signal enhancement observed in 
the 1H NMR spectra collected using pyridazine was 1278-fold 
with a /2 pulse. Normally, the S/N value associated with a 
given resonance is proportional to concentration. Here, 
however, the S/N value is linked to the product of the 
concentration and the hyperpolarisation level. An 
approximately linear dependence on the detected signal 
strength with concentration was observed experimentally for 
samples in which the substrate concentration lay between 2.8 
mM and 6.2 mM, as shown in Figure 8. We conclude from 
these observations that there is no benefit in working at higher 
concentration, even if there is an abundance of the available 
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substrate, since the fall in SABRE level acts to offset the signal 
gain resulting from an increase in concentration.68, 69  
 
Figure 8. Plots of S/N (upper), and the indicated hyperpolarised 1H NMR signal 
intensities (lower) of pyridazine as a function of concentration 
3.13. Probing the effect of the polarisation transfer field on 
the efficiency of SABRE. The variation in the level of SABRE 
observed with the magnetic field experienced by the sample at 
the point of polarisation transfer is substantial (see SI). Both 
substrates behave in a similar way, each yielding their largest 
free ligand single spin enhancement values when the 
polarisation transfer field is 65 G. Consequently, this field 
should be used for detection. SABRE, however, also creates 
higher order magnetic terms which are optimally enhanced at 
different field values (see SI).70 It is possible to selectively 
observe the signals from these substrates without the need for a 
deuterated solvent by employing the OPSY protocol as shown 
in Figure 9.71, 72   
 a)  
(b)  
Figure 9. Double quantum selected 
1
H NMR spectra of protio-methanol solutions 
of 1 (5.2 mM) containing 5 equivalents of pyridazine (a), and phthalazine (b) 
after SABRE. Free substrate resonances are indicated (stars). 
 
 
3.14. SABRE enhancements delivered by 
[Ir(H)2(IMes)(pdz)3]Cl (4a) and [Ir(H)2(IMes)(phth)3]Cl 
(4b) as a function of the polarisation transfer time. 
Increasing the time that these samples are exposed to p-H2 
during the SABRE step further increases the level of signal 
enhancement. The plots in SI sFigure 13-23 show how the 
resonance intensities vary with the polarisation transfer time. 
Ultimately, the maximum polarisation level reaches a plateau as 
T1(effective) of the probed state counteracts the rate of SABRE 
build-up. The polarisation builds up most quickly in the single 
spin NCH protons, and ultimately reaches a higher polarisation 
level than any other spin state. While the observed rate of two-
spin order build up is comparable to that of a single spin their 
ultimate amplitudes are lower as a consequence of their more 
rapid relaxation (se SI).   
3.15. Using SABRE to collect MRI data. We recorded a series 
of SABRE images and compared them to their thermal 
counterparts (Figure 10). As expected, these images exhibited 
better signal to noise, improved contrast, and signal intensity. 
Furthermore, the samples of pyridazine were superior to those 
of phthalazine in terms of signal intensity (one order of 
magnitude higher) for the same concentration of substrate. 
 
 
Figure 10. Hyperpolarised images of pyridazine (upper, left) and phthalazine 
(lower left) compared to their respective thermally equilibrated images (right).  
In order to more precisely quantify the improvement in image 
quality, five one-shot images of the hyperpolarised samples 
were acquired and the resulting image SNR’s calculated. The 
average result was divided by the SNR of a reference image 
that was recorded under Boltzmann equilibrium conditions 
using 512 averages. The underlying improvement in contrast 
and image quality is revealed in Table 5. A considerable 
increase in the SNR values was observed, and the acquisition 
times required for SABRE images were 6 orders of magnitude 
smaller than the scan times necessary under thermal 
equilibrium conditions (260 ms versus several hours). 
The optimum conditions used to hyperpolarise both pyridazine 
and phthalazine in methanol, at 298 K, have been applied to 5-
aminophthalazine, which has antifungal properties.73 
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Preliminary results are very promising – with total signal 
enhancements of ca. 500-fold being observed. The applicability 
of SABRE, in hyperpolarising pyridazine and phthalazine-
derived drug molecules for use as contrast agents, is dependent 
ultimately on performance in biologically-compatible solvents. 
Although water would seem an obvious solvent choice, SABRE 
has not yet been shown to work efficiently in this medium.37, 39 
An ethanol-water mixture is, however, biocompatible, hence 
the use of ethanol, followed by dilution has been predicted to be 
viable.70, 74 We have therefore examined pyridazine and 
phthalazine in ethanol-d6. Our preliminary results reveal 
superior SABRE in this solvent, with the pyridazine signal 
enhancement of ca. 400–fold (9.62–fold excess, 60 mM free 
pyridazine) being 33% better than in methanol. For phthalazine 
the total signal enhancement was 480-fold (2.12-fold excess, 
13.2 mM free phthalazine) or 20% better. Our studies on 5-
aminophthalazine confirm that further functionalisation of the 
remote ring will not prevent SABRE activity and an array of 
such materials could be probed.75 
 
Table 5. Average, and maximum values, of the absolute SNR 
observed in the processed images of hyperpolarised pyridazine 
and phthalazine and the ratios of hyperpolarised to reference 
image SNR respectively. 
4. CONCLUSIONS 
We have established that [Ir(IMes)(COD)Cl] (1) reacts rapidly 
with pyridazine and phthalazine to form the ligand substitution 
products [Ir(IMes)(COD)(pdz)]Cl, 2a and 
[Ir(IMes)(COD)(phth)]Cl 2b, respectively. Phthalazine is more 
basic than pyridazine, and  2b is more stable than 2a.76 These 
complexes undergo a haptotropic shift on the NMR timescale 
which is more rapid for 2b.  
Complexes 2a and 2b add H2 to form the corresponding Ir(III) 
complexes [Ir(H)2(COD)(IMes)(pdz)]Cl (3a) and 
[Ir(H)2(COD)(IMes)(phth)]Cl (3b), where 3b is more stable 
than 3a. When the H2 addition reaction was monitored with p-
H2, PHIP was observed in the hydride NMR signals of these 
two products and 2a is more reactive to H2 addition than 2b. 3a 
and 3b also exhibit SABRE in specific ligand resonances that 
lie trans to the hydrides. This demonstrates that 
hyperpolarisation can be used to characterise such complexes, 
even if they have a transient existence.  
3a and 3b are highly reactive and upon warming they rapidly 
convert to the dihydrides [Ir(H)2(IMes)(pdz)3]Cl (4a) and 
[Ir(H)2(IMes)(phth)3]Cl (4b). These two complexes also 
undergo a haptotropic ligand shift in addition to full ligand loss 
on the NMR timescale. The iridium-nitrogen bonds of 4a are 
stronger than those of 4b. The hyperpolarisation of both 
pyridazine and phthalazine by 4a and 4b respectively, under 
SABRE, proved to be facile. NMR enhancements increase with 
temperature, due to faster ligand exchange, and are optimised 
with 5 equivalents of substrate, and a polarisation transfer field 
of 65 G. An optimised enhancement level, at 298 K, of 1278-
fold was achieved for pyridazine.  
The total signal enhancement of pyridazine was consistently 
larger than that of phthalazine even though the ligand loss rates 
of 4a and 4b were comparable. This difference in behaviour 
cannot be accounted for by the sharing of magnetisation from 
p-H2 with 4 rather than 6 receptor protons, but instead suggests 
that the J-coupling between the hydride and Ir-NCH protons of 
pyridazine is larger than that to phthalazine. This deduction 
agrees with the predicted shorter Ir-N bond length in 4a. A 
series of more complex magnetic states can also be created 
which allow the observation of these substrates in protio 
solvents through the OPSY protocol.   
Finally, we have shown that it is possible to collect optimised 
MRI images for these substrates on phantoms. Whilst neither 
pyridazine nor phthalazine are used clinically, their derivatives, 
in the form of drugs such as Hydralazine,77 play an important 
role in medicine; we have polarised 5-aminophthalazine which 
has antifungal properties and achieved total enhancement levels 
of 500-fold. In the future, we plan to use the results of this 
study to aid in the optimisation of SABRE for the analysis of 
similar heterocycles that are used pharmaceutically.  
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